Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

In Immunology, J&J Makes A Big Move On Biologic Combinations

Fri, 05/24/2019 - 11:32am

The company has initiated a Phase II study of Tremfya and Simponi in combination for the treatment of ulcerative colitis...

      Related Stories 

Pipeline Watch: Phase III Starts For Nirogacestat, Etrasimod

Fri, 05/24/2019 - 7:25am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

GSK Revamps Sales Reps Incentives To Be Competitive In Cancer

Fri, 05/24/2019 - 6:33am

Seven years after a major shift in how the company compensated its sales force, the UK major has done a...

      Related Stories 

AZ, Takeda, Novartis Praised For Medicines Access Work But More Is Needed

Fri, 05/24/2019 - 2:42am

The 20 major companies in the Access to Medicines Index have made progress in areas like inclusive business models, R&D...

      Related Stories 

Cipla Claims Pricing Advantage For Albuterol In US

Thu, 05/23/2019 - 4:51pm

Cipla, which expects to enter the US albuterol inhalation market later this year, believes that it has the cost competitiveness...

      Related Stories 

Targovax Pivots Towards Oncolytic Viruses

Thu, 05/23/2019 - 7:36am

Oncolytic virus-based therapies which act as immune activators will be the only candidates in the Norwegian biotech’s pipeline from now...

      Related Stories 

Finance Watch: Q1 Numbers Suggest A Brisk VC Deal Pace For Cell And Gene Therapies In 2019

Wed, 05/22/2019 - 8:17pm

An Alliance for Regenerative Medicine (ARM) report shows big Q1 numbers for venture capital and partnership deals. Also, mid-May VC...

      Related Stories 

ElevateBio Announces AlloVir As First Spoke In Its Cell And Gene Therapy Hub

Wed, 05/22/2019 - 8:10pm

ElevateBio revealed the first company to hitch up with its newly established centralized cell and gene therapy development, manufacturing and...

      Related Stories 

China Forced Tech Transfer Still A Problem, EU Firms Say

Wed, 05/22/2019 - 5:38pm

One in five European pharma companies and medical devices makers has been forced to transfer technologies in China, a fact...

      Related Stories 

Mixed Responses To BioCryst's Oral Phase III HAI Therapy, BCX7353

Wed, 05/22/2019 - 9:08am

BioCryst’s BCX7353 could be the first oral therapy to prevent hereditary angioedema attacks, but it might not work in all...

      Related Stories 

Lured By Its Discovery Platform And Pipeline, Amgen Bids For Nuevolution

Wed, 05/22/2019 - 7:27am

Amgen offered to buy its Scandinavian discovery partner for $166.8m to gain access to Nuevolution’s DNA-encoded drug discovery platform and...

      Related Stories